Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases
S Wang, B Liang, W Wang, L Li, N Feng… - Signal transduction and …, 2023 - nature.com
Human diseases, particularly infectious diseases and cancers, pose unprecedented
challenges to public health security and the global economy. The development and …
challenges to public health security and the global economy. The development and …
Advances in development and application of influenza vaccines
J Chen, J Wang, J Zhang, H Ly - Frontiers in immunology, 2021 - frontiersin.org
Influenza A virus is one of the most important zoonotic pathogens that can cause severe
symptoms and has the potential to cause high number of deaths and great economic loss …
symptoms and has the potential to cause high number of deaths and great economic loss …
Ebola haemorrhagic fever
H Feldmann, TW Geisbert - The Lancet, 2011 - thelancet.com
Ebola viruses are the causative agents of a severe form of viral haemorrhagic fever in man,
designated Ebola haemorrhagic fever, and are endemic in regions of central Africa. The …
designated Ebola haemorrhagic fever, and are endemic in regions of central Africa. The …
[HTML][HTML] Ebola virus disease: An emerging and re-emerging viral threat
The genus Ebolavirus from the family Filoviridae is composed of five species including
Sudan ebolavirus, Reston ebolavirus, Bundibugyo ebolavirus, Taï Forest ebolavirus, and …
Sudan ebolavirus, Reston ebolavirus, Bundibugyo ebolavirus, Taï Forest ebolavirus, and …
Recombinant vesicular stomatitis virus–based vaccines against Ebola and Marburg virus infections
TW Geisbert, H Feldmann - The Journal of infectious diseases, 2011 - academic.oup.com
The filoviruses, Marburg virus and Ebola virus, cause severe hemorrhagic fever with a high
mortality rate in humans and nonhuman primates. Among the most-promising filovirus …
mortality rate in humans and nonhuman primates. Among the most-promising filovirus …
Clinical features and pathobiology of Ebolavirus infection
AA Ansari - Journal of autoimmunity, 2014 - Elsevier
There has clearly been a deluge of international press coverage of the recent outbreak of
Ebolavirus in Africa and is partly related to the “fear factor” that comes across when one is …
Ebolavirus in Africa and is partly related to the “fear factor” that comes across when one is …
Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus
TW Geisbert, JB Geisbert, A Leung… - Journal of …, 2009 - Am Soc Microbiol
The filoviruses Marburg virus and Ebola virus cause severe hemorrhagic fever with high
mortality in humans and nonhuman primates. Among the most promising filovirus vaccines …
mortality in humans and nonhuman primates. Among the most promising filovirus vaccines …
The ecology of Ebola virus
A Groseth, H Feldmann, JE Strong - Trends in microbiology, 2007 - cell.com
Since Ebola virus was first identified more than 30 years ago, tremendous progress has
been made in understanding the molecular biology and pathogenesis of this virus. However …
been made in understanding the molecular biology and pathogenesis of this virus. However …
A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults
JE Ledgerwood, P Costner, N Desai, L Holman… - Vaccine, 2010 - Elsevier
Ebola virus causes irregular outbreaks of severe hemorrhagic fever in equatorial Africa.
Case mortality remains high; there is no effective treatment and outbreaks are sporadic and …
Case mortality remains high; there is no effective treatment and outbreaks are sporadic and …
Ebola virus vaccines: an overview of current approaches
A Marzi, H Feldmann - Expert review of vaccines, 2014 - Taylor & Francis
Ebola hemorrhagic fever is one of the most fatal viral diseases worldwide affecting humans
and nonhuman primates. Although infections only occur frequently in Central Africa, the …
and nonhuman primates. Although infections only occur frequently in Central Africa, the …